Darpp-32 and t-Darpp protein products of PPP1R1B: old dogs with new tricks.
We present a case for the development of an anti-t-Darpp therapeutic agent and outline the unique challenges this endeavor will likely encounter.
PMID: 30552871 [PubMed - as supplied by publisher]
Source: Biochemical Pharmacology - Category: Drugs & Pharmacology Authors: Avanes BA, Lenz G, Momand J Tags: Biochem Pharmacol Source Type: research
More News: Brain | Brain Cancers | Breast Cancer | Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer | Drugs & Pharmacology | Esophagus Cancer | Gastric (Stomach) Cancer | Gastroenterology | Genetics | HER2 | Herceptin | Learning | Neurology | Science | Universities & Medical Training